Clinical Trials › NCT05119569
Active, Not RecruitingPhase 2
A Study to Investigate the Efficacy of Fenebrutinib in Relapsing Multiple Sclerosis (RMS)
Sponsored by Hoffmann-La Roche
Interested in joining? Eligibility criteria and contact info are on ClinicalTrials.gov.
View on ClinicalTrials.gov 109
Target enrollment
2
U.S. states
Mar 2022
Start date
Dec 2026
Expected completion
Interventions / Treatments
FenebrutinibPlacebo
Conditions studied
Relapsing Multiple Sclerosis
Where this trial is running (2 sites)
California1 site
Fullerton
Nevada1 site
Las Vegas
Participating MS centers on MS Buddy (1)
Fullerton Neurology and Headache Center
Fullerton, CA
Fullerton, CA
MS centers in California
Compare treatment centers near a trial site — patient experience, providers, and care ratings.
View California centersMore Phase 2 trials
Browse all Phase 2 MS trialsCheck out the MS Buddy App
Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.
